These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 38621943

  • 1. [Effect of Zuogui Jiangtang Qinggan Formula on lipid metabolism in db/db mouse model of type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease].
    Zhou M, Li L, Zou JJ, Liu X, Wu YJ, Xiang Q, Yu R.
    Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(6):1587-1593. PubMed ID: 38621943
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Zuogui Jiangtang Qinggan Formula improves glucolipid metabolism in type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease by regulating FoxO1/MTP/APOB signaling pathway].
    Xiang YX, Huang YL, Zhou M, Zou JJ, Liu X, Liu ZY, Xiao F, Yu R, Xiang Q.
    Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(16):4438-4445. PubMed ID: 37802870
    [Abstract] [Full Text] [Related]

  • 4. [Zuogui Jiangtang Qinggan Prescription promotes recovery of intestinal mucosal barrier in mice with type 2 diabetes mellitus and nonalcoholic fatty liver disease by improving intestinal flora homeostasis].
    Zou JJ, Li H, Zhou M, Huang QQ, Wu YJ, Yu R.
    Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(2):525-533. PubMed ID: 36725242
    [Abstract] [Full Text] [Related]

  • 5. [Effect of Danlou Tablets on alleviating hepatic adipogenesis, inflammatory response, and insulin resistance in db/db mice].
    Pang YF, Huang M, Li L, Zhao X, Zhang HX, Li YH.
    Zhongguo Zhong Yao Za Zhi; 2022 Jun; 47(12):3320-3327. PubMed ID: 35851126
    [Abstract] [Full Text] [Related]

  • 6. Zuogui-Jiangtang-Qinggan-Fang alleviates high-fat diet-induced type 2 diabetes mellitus with non-alcoholic fatty liver disease by modulating gut microbiome-metabolites-short chain fatty acid composition.
    Zou J, Xiang Q, Tan D, Shi L, Liu X, Wu Y, Yu R.
    Biomed Pharmacother; 2023 Jan; 157():114002. PubMed ID: 36410120
    [Abstract] [Full Text] [Related]

  • 7. Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice.
    Luo L, Fang K, Dan X, Gu M.
    Lipids Health Dis; 2019 Jan 08; 18(1):11. PubMed ID: 30621686
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Gracilaria chorda subcritical water ameliorates hepatic lipid accumulation and regulates glucose homeostasis in a hepatic steatosis cell model and obese C57BL/6J mice.
    Thakuri LS, Park CM, Kim HA, Kim HJ, Park JW, Park JC, Rhyu DY.
    J Ethnopharmacol; 2024 Feb 10; 320():117395. PubMed ID: 37952731
    [Abstract] [Full Text] [Related]

  • 10. Si-Ni-San inhibits hepatic Fasn expression and lipid accumulation in MAFLD mice through AMPK/p300/SREBP-1c axis.
    Lan T, Geng XJ, Zhang SJ, Zeng XX, Ying JJ, Xu Y, Liu SY, Li P, Tong YH, Wang W, Mao ZJ, Wang SW.
    Phytomedicine; 2024 Jan 10; 123():155209. PubMed ID: 37984123
    [Abstract] [Full Text] [Related]

  • 11. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
    Zhu X, Bian H, Wang L, Sun X, Xu X, Yan H, Xia M, Chang X, Lu Y, Li Y, Xia P, Li X, Gao X.
    Free Radic Biol Med; 2019 Sep 10; 141():192-204. PubMed ID: 31226399
    [Abstract] [Full Text] [Related]

  • 12. Xiaozhi formula attenuates non-alcoholic fatty liver disease by regulating lipid metabolism via activation of AMPK and PPAR pathways.
    You L, Wang T, Li W, Zhang J, Zheng C, Zheng Y, Li S, Shang Z, Lin J, Wang F, Qian Y, Zhou Z, Kong X, Gao Y, Sun X.
    J Ethnopharmacol; 2024 Jul 15; 329():118165. PubMed ID: 38588984
    [Abstract] [Full Text] [Related]

  • 13. [Effect of zhenqing recipe on non-alcoholic fatty liver in type 2 diabetes rats and the expression of SIK1].
    Zheng H, Hong SC, Yu J, Wen XY.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Jul 15; 34(7):846-52. PubMed ID: 25137852
    [Abstract] [Full Text] [Related]

  • 14. Topical rhubarb charcoal-crosslinked chitosan/silk fibroin sponge scaffold for the repair of diabetic ulcers improves hepatic lipid deposition in db/db mice via the AMPK signalling pathway.
    Tan Q, He Q, Peng Z, Zeng X, Liu Y, Li D, Wang S, Wang J.
    Lipids Health Dis; 2024 Feb 20; 23(1):52. PubMed ID: 38378566
    [Abstract] [Full Text] [Related]

  • 15. [Effect of Fuzi Lizhong decoction in reducing liver injury of rats with non-alcoholic fatty liver via activating AMPK and suppressing NF-κBp65 pathway].
    Yang JY, Shi ZH, Ma W, Tao DQ, Liu S, Chen L, Zhou XL.
    Zhongguo Zhong Yao Za Zhi; 2018 Aug 20; 43(15):3176-3183. PubMed ID: 30200715
    [Abstract] [Full Text] [Related]

  • 16. Schisandrin B ameliorates non-alcoholic liver disease through anti-inflammation activation in diabetic mice.
    Ma R, Zhan Y, Zhang Y, Wu L, Wang X, Guo M.
    Drug Dev Res; 2022 May 20; 83(3):735-744. PubMed ID: 34927282
    [Abstract] [Full Text] [Related]

  • 17. [Diosgenin alleviates NAFLD induced by a high-fat diet in rats via mTOR/SREBP-1c/HSP60/MCAD/SCAD signaling pathway].
    Chen SW, Yin GL, Song CY, Meng DC, Yu WF, Zhang X, Feng YN, Liang PP, Zhang FX.
    Zhongguo Zhong Yao Za Zhi; 2023 Oct 20; 48(19):5304-5314. PubMed ID: 38114120
    [Abstract] [Full Text] [Related]

  • 18. Flavonoids extracted from mulberry (Morus alba L.) leaf improve skeletal muscle mitochondrial function by activating AMPK in type 2 diabetes.
    Meng Q, Qi X, Fu Y, Chen Q, Cheng P, Yu X, Sun X, Wu J, Li W, Zhang Q, Li Y, Wang A, Bian H.
    J Ethnopharmacol; 2020 Feb 10; 248():112326. PubMed ID: 31639486
    [Abstract] [Full Text] [Related]

  • 19. Kaempferol attenuates nonalcoholic fatty liver disease in type 2 diabetic mice via the Sirt1/AMPK signaling pathway.
    Li N, Yin L, Shang J, Liang M, Liu Z, Yang H, Qiang G, Du G, Yang X.
    Biomed Pharmacother; 2023 Sep 10; 165():115113. PubMed ID: 37418974
    [Abstract] [Full Text] [Related]

  • 20. [Mechanism of Astragali Radix-Puerariae Lobatae Radix combination in regulating type 2 diabetes mellitus through AMPK signaling pathway: based on network pharmacology and experimental verification].
    Wei S, Li J, Han DW, Fu Q, Hao F.
    Zhongguo Zhong Yao Za Zhi; 2022 May 10; 47(10):2738-2749. PubMed ID: 35718494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.